共 43 条
[1]
Boehner H(2000)Detection and prognosis of recurrent gastric cancer—is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology 47 1489-1494
[2]
Zimmer T(1998)Modified therapy with 5-fluorouracil, doxorubicin and methotrexate in advanced gastric cancer Oncology (Huntingt) 12 179-223
[3]
Hopfenmueller W(1993)Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer Cancer 72 37-41
[4]
Berger G(1997)Randomized comparison of 5-fluorouracil, epidoxorubicin, and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer Ann Oncol 8 163-168
[5]
Buhr HJ(1995)Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer Br J Cancer 71 587-591
[6]
Murad AM(1999)Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 in advanced gastric cancer patients J Clin Oncol 17 319-323
[7]
Santiago FF(1998)Recurrence following curative resection for gastric carcinoma Eur J Cancer 34 1715-1720
[8]
Petroianu A(2000)Evaluation of a follow-up programme after curative resection for colorectal cancer Br J Surg 87 236-242
[9]
Rocha PR(1999)A new macroscopic classification predicts prognosis for patients with liver metastases from colorectal cancer Br J Cancer 79 308-310
[10]
Rodrigues MA(1997)Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer Ann Surg 226 582-586